Literature DB >> 29752639

Prevalence of HIV Viral Load Suppression Among Psychiatric Inpatients with Comorbid Substance Use Disorders.

D M Coviello1,2, R Lovato3, K Apostol3, M M Eisenberg3, D S Metzger3, R Szucs-Reed3, N Kiryankova-Dalseth4, D Kelly3, A Jackson3, M Plano3, M B Blank3.   

Abstract

A consistently suppressed viral load enables HIV (+) patients to live longer, healthier lives and reduces the probability of transmitting the virus. Since the prevalence of HIV is four times higher among those with psychiatric disorders than in the general population, it is likely that this group would also have greater difficulty remaining in care and achieving viral suppression. A secondary data analysis utilizing screening data from the Preventing AIDS Through Health (PATH) for Triples (PFT) Study were examined to assess HIV load suppression among 254 psychiatric inpatients with comorbid substance use disorders in Philadelphia. Viral load results from the past 12 months were obtained from medical records for 63 inpatients identified as HIV (+). The sample was predominately African American (76%), male (56%), and the average age was 43 years. Psychiatric disorders included depression (64%), schizophrenia (21%), and bipolar disorder (13%) with patients reporting use of alcohol (73%), cocaine (64%), cannabis (29%) and opioids (16%) prior to admission. Among this high risk sample of HIV (+) patients, about one-half (52%) achieved viral suppression, with recent opioid users six times more likely to have a detectable viral load than non-opioid users (OR 6.0; CI 1.1-31.7, p = .035). The 52% viral load suppression rate among psychiatric inpatient was higher than expected, given that the CDC's national suppression rate among those diagnosed with HIV in the general population is 58%. However, individuals with mental illness and substance use disorders require constant surveillance, monitoring, and supportive services to achieve viral suppression. Many of those who were virally suppressed were engaged in Philadelphia's extensive treatment network, whereas those who were detectable and enrolled in the PFT intervention were often homeless with unstable psychiatric symptoms and current substance use disorders, particularly opioid abuse.

Entities:  

Keywords:  HIV; HIV viral load; Mental health; Psychiatric inpatients; Substance use disorders

Mesh:

Substances:

Year:  2018        PMID: 29752639      PMCID: PMC6230497          DOI: 10.1007/s10597-018-0284-2

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  36 in total

1.  Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

Authors:  Julia H Arnsten; Penelope A Demas; Richard W Grant; Marc N Gourevitch; Homayoon Farzadegan; Andrea A Howard; Ellie E Schoenbaum
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

2.  Psychiatric morbidity and adherence to antiretroviral medication in patients with HIV/AIDS.

Authors:  Peter S Sternhell; Melissa J Corr
Journal:  Aust N Z J Psychiatry       Date:  2002-08       Impact factor: 5.744

3.  Factors Influencing the Delivery of HIV-Related Services to Severely Mentally Ill Individuals: The Provider's Perspective.

Authors:  Monica Biradavolu; Yujiang Jia; Keenan Withers; Suad Kapetanovic
Journal:  Psychosomatics       Date:  2015-08-01       Impact factor: 2.386

4.  Psychosocial factors and medication adherence in HIV-positive youth.

Authors:  Sylvie Naar-King; Thomas Templin; Kathryn Wright; Maureen Frey; Jeffrey T Parsons; Phebe Lam
Journal:  AIDS Patient Care STDS       Date:  2006-01       Impact factor: 5.078

5.  A randomized trial of a nursing intervention for HIV disease management among persons with serious mental illness.

Authors:  Michael B Blank; Nancy P Hanrahan; Martin Fishbein; Evan S Wu; Julie A Tennille; Thomas R Ten Have; Ann M Kutney-Lee; Robert Gross; Janet M Hines; James C Coyne; Linda H Aiken
Journal:  Psychiatr Serv       Date:  2011-11       Impact factor: 3.084

6.  HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study.

Authors:  Jaimie P Meyer; Javier Cepeda; Sandra A Springer; Johnny Wu; Robert L Trestman; Frederick L Altice
Journal:  Lancet HIV       Date:  2014-11-01       Impact factor: 12.767

7.  CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.

Authors:  Jason V Baker; Grace Peng; Joshua Rapkin; Donald I Abrams; Michael J Silverberg; Rodger D MacArthur; Winston P Cavert; W Keith Henry; James D Neaton
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

8.  Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.

Authors:  McKaylee Robertson; Fabienne Laraque; Heather Mavronicolas; Sarah Braunstein; Lucia Torian
Journal:  AIDS Care       Date:  2014-09-22

9.  Grand challenges: Improving HIV treatment outcomes by integrating interventions for co-morbid mental illness.

Authors:  Sylvia Kaaya; Eddy Eustache; Ilana Lapidos-Salaiz; Seggane Musisi; Christina Psaros; Lawrence Wissow
Journal:  PLoS Med       Date:  2013-05-21       Impact factor: 11.069

10.  Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.

Authors:  Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-10       Impact factor: 17.586

View more
  6 in total

1.  Moderating effects of social support on the relationship between substance use disorders and HIV viral load and medication adherence among Black women living with HIV in the United States.

Authors:  Rachelle Reid; Sannisha K Dale
Journal:  AIDS Care       Date:  2021-11-16

2.  Correlates and cascade of HIV care in patients with psychiatric disorders in the Eastern Cape province, South Africa.

Authors:  Adila Aboobaker; Zukiswa Zingela; Oladele V Adeniyi
Journal:  S Afr J Psychiatr       Date:  2022-02-15       Impact factor: 1.550

3.  Identifying Potential Factors Associated with High HIV viral load in KwaZulu-Natal, South Africa using Multiple Correspondence Analysis and Random Forest Analysis.

Authors:  Adenike O Soogun; Ayesha B M Kharsany; Temesgen Zewotir; Delia North; Ropo Ebenezer Ogunsakin
Journal:  BMC Med Res Methodol       Date:  2022-06-17       Impact factor: 4.612

4.  Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV.

Authors:  Amy J Kennedy; Kathleen A McGinnis; Jessica S Merlin; E Jennifer Edelman; Adam J Gordon; P Todd Korthuis; Melissa Skanderson; Emily C Williams; Jessica Wyse; Benjamin Oldfield; Kendall Bryant; Amy Justice; David A Fiellin; Kevin L Kraemer
Journal:  J Subst Abuse Treat       Date:  2021-05-29

Review 5.  The Educational Value of Outpatient Consultation-Liaison Rotations: A White Paper From the Academy of Consultation-Liaison Psychiatry Residency Education Subcommittee.

Authors:  Paula C Zimbrean; Carrie L Ernst; Ariadna Forray; Scott R Beach; Mallika Lavakumar; Andrew M Siegel; Thomas Soeprono; Ann C Schwartz
Journal:  Psychosomatics       Date:  2020-05-19       Impact factor: 2.386

Review 6.  Integrating Screening and Treatment of Unhealthy Alcohol Use and Depression with Screening and Treatment of Anxiety, Pain, and Other Substance Use Among People with HIV and Other High-Risk Persons.

Authors:  Ellen C Caniglia; Maria Khan; Kaoon Ban; R Scott Braithwaite
Journal:  AIDS Behav       Date:  2021-04-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.